Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects
An Open-label Extension Study of the Long-term Safety, Tolerability and Efficacy of Drisapersen in US and Canadian Subjects With Duchenne Muscular Dystrophy.
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects
An Open-label Extension Study of the Long-term Safety, Tolerability and Efficacy of Drisapersen in US and Canadian Subjects With Duchenne Muscular Dystrophy.
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects
An Open-label Extension Study of the Long-term Safety, Tolerability and Efficacy of Drisapersen in US and Canadian Subjects With Duchenne Muscular Dystrophy.
Status: Enrolling
Updated:  12/31/1969
Shriners Hospitals for Children
mi
from
Portland, OR
A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects
An Open-label Extension Study of the Long-term Safety, Tolerability and Efficacy of Drisapersen in US and Canadian Subjects With Duchenne Muscular Dystrophy.
Status: Enrolling
Updated: 12/31/1969
Shriners Hospitals for Children
mi
from
Portland, OR
Click here to add this to my saved trials
A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects
An Open-label Extension Study of the Long-term Safety, Tolerability and Efficacy of Drisapersen in US and Canadian Subjects With Duchenne Muscular Dystrophy.
Status: Enrolling
Updated:  12/31/1969
Children's & Women's Health Centre of BC
mi
from
Vancouver,
A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects
An Open-label Extension Study of the Long-term Safety, Tolerability and Efficacy of Drisapersen in US and Canadian Subjects With Duchenne Muscular Dystrophy.
Status: Enrolling
Updated: 12/31/1969
Children's & Women's Health Centre of BC
mi
from
Vancouver,
Click here to add this to my saved trials
The PREMOD Trial: A Randomized Controlled Trial of Umbilical Cord Milking vs. Delayed Cord Clamping in Premature Infants
The PREMOD Trial: A Randomized Controlled Trial of Umbilical Cord Milking vs. Delayed Cord Clamping in Premature Infants
Status: Enrolling
Updated:  12/31/1969
Loma Linda Medical Center
mi
from
Loma Linda, CA
The PREMOD Trial: A Randomized Controlled Trial of Umbilical Cord Milking vs. Delayed Cord Clamping in Premature Infants
The PREMOD Trial: A Randomized Controlled Trial of Umbilical Cord Milking vs. Delayed Cord Clamping in Premature Infants
Status: Enrolling
Updated: 12/31/1969
Loma Linda Medical Center
mi
from
Loma Linda, CA
Click here to add this to my saved trials
The PREMOD Trial: A Randomized Controlled Trial of Umbilical Cord Milking vs. Delayed Cord Clamping in Premature Infants
The PREMOD Trial: A Randomized Controlled Trial of Umbilical Cord Milking vs. Delayed Cord Clamping in Premature Infants
Status: Enrolling
Updated:  12/31/1969
Sharp Mary Birch
mi
from
San Diego, CA
The PREMOD Trial: A Randomized Controlled Trial of Umbilical Cord Milking vs. Delayed Cord Clamping in Premature Infants
The PREMOD Trial: A Randomized Controlled Trial of Umbilical Cord Milking vs. Delayed Cord Clamping in Premature Infants
Status: Enrolling
Updated: 12/31/1969
Sharp Mary Birch
mi
from
San Diego, CA
Click here to add this to my saved trials
The PREMOD Trial: A Randomized Controlled Trial of Umbilical Cord Milking vs. Delayed Cord Clamping in Premature Infants
The PREMOD Trial: A Randomized Controlled Trial of Umbilical Cord Milking vs. Delayed Cord Clamping in Premature Infants
Status: Enrolling
Updated:  12/31/1969
University of California, San Diego
mi
from
San Diego, CA
The PREMOD Trial: A Randomized Controlled Trial of Umbilical Cord Milking vs. Delayed Cord Clamping in Premature Infants
The PREMOD Trial: A Randomized Controlled Trial of Umbilical Cord Milking vs. Delayed Cord Clamping in Premature Infants
Status: Enrolling
Updated: 12/31/1969
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Raltegravir for HAM/TSP
Pilot Study of Raltegravir, an Integrase Inhibitor, in Human T-Cell Lymphotrophic Virus-1(HTLV-1) Associated Myelopathy, Tropical Spastic Paraparesis (HAM/TSP)
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Raltegravir for HAM/TSP
Pilot Study of Raltegravir, an Integrase Inhibitor, in Human T-Cell Lymphotrophic Virus-1(HTLV-1) Associated Myelopathy, Tropical Spastic Paraparesis (HAM/TSP)
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Peanut Oral Immunotherapy in Children
Oral Immunotherapy for Induction of Tolerance and Desensitization in Peanut-Allergic Children (ITN050AD)
Status: Enrolling
Updated:  12/31/1969
University of Arkansas for Medical Sciences; Arkansas Children's Hospital
mi
from
Little Rock, AR
Peanut Oral Immunotherapy in Children
Oral Immunotherapy for Induction of Tolerance and Desensitization in Peanut-Allergic Children (ITN050AD)
Status: Enrolling
Updated: 12/31/1969
University of Arkansas for Medical Sciences; Arkansas Children's Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
Peanut Oral Immunotherapy in Children
Oral Immunotherapy for Induction of Tolerance and Desensitization in Peanut-Allergic Children (ITN050AD)
Status: Enrolling
Updated:  12/31/1969
Stanford University School of Medicine
mi
from
Stanford, CA
Peanut Oral Immunotherapy in Children
Oral Immunotherapy for Induction of Tolerance and Desensitization in Peanut-Allergic Children (ITN050AD)
Status: Enrolling
Updated: 12/31/1969
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Peanut Oral Immunotherapy in Children
Oral Immunotherapy for Induction of Tolerance and Desensitization in Peanut-Allergic Children (ITN050AD)
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Peanut Oral Immunotherapy in Children
Oral Immunotherapy for Induction of Tolerance and Desensitization in Peanut-Allergic Children (ITN050AD)
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Peanut Oral Immunotherapy in Children
Oral Immunotherapy for Induction of Tolerance and Desensitization in Peanut-Allergic Children (ITN050AD)
Status: Enrolling
Updated:  12/31/1969
Mount Sinai School of Medicine
mi
from
New York, NY
Peanut Oral Immunotherapy in Children
Oral Immunotherapy for Induction of Tolerance and Desensitization in Peanut-Allergic Children (ITN050AD)
Status: Enrolling
Updated: 12/31/1969
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Peanut Oral Immunotherapy in Children
Oral Immunotherapy for Induction of Tolerance and Desensitization in Peanut-Allergic Children (ITN050AD)
Status: Enrolling
Updated:  12/31/1969
UNC Chapel Hill
mi
from
CHapel Hill, NC
Peanut Oral Immunotherapy in Children
Oral Immunotherapy for Induction of Tolerance and Desensitization in Peanut-Allergic Children (ITN050AD)
Status: Enrolling
Updated: 12/31/1969
UNC Chapel Hill
mi
from
CHapel Hill, NC
Click here to add this to my saved trials
Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas
Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas
Status: Enrolling
Updated:  12/31/1969
New York University School of Medicine
mi
from
New York, NY
Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas
Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas
Status: Enrolling
Updated: 12/31/1969
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Remotely Deployed TBI Study
Remotely Deployed Training for Cognitive Impairment Associated With TBI
Status: Enrolling
Updated:  12/31/1969
VA Northern California Health Care System
mi
from
Martinez, CA
Remotely Deployed TBI Study
Remotely Deployed Training for Cognitive Impairment Associated With TBI
Status: Enrolling
Updated: 12/31/1969
VA Northern California Health Care System
mi
from
Martinez, CA
Click here to add this to my saved trials
Remotely Deployed TBI Study
Remotely Deployed Training for Cognitive Impairment Associated With TBI
Status: Enrolling
Updated:  12/31/1969
San Francisco VA Medical Center
mi
from
San Francisco, CA
Remotely Deployed TBI Study
Remotely Deployed Training for Cognitive Impairment Associated With TBI
Status: Enrolling
Updated: 12/31/1969
San Francisco VA Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Virtual Walking for Neuropathic Pain in Spinal Cord Injury
Virtual Walking for Reducing Spinal Cord Injury-Related Neuropathic Pain
Status: Enrolling
Updated:  12/31/1969
Spain REhabilitation Center
mi
from
Birmingham, AL
Virtual Walking for Neuropathic Pain in Spinal Cord Injury
Virtual Walking for Reducing Spinal Cord Injury-Related Neuropathic Pain
Status: Enrolling
Updated: 12/31/1969
Spain REhabilitation Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Clinical Characteristics of Dementias That Occur Remotely After Traumatic Brain Injury in Retired Military Personnel
Endophenotypes of Dementia Associated With Traumatic Brain Injury in Retired Military Personnel
Status: Enrolling
Updated:  12/31/1969
California Veterans Home-Yountville
mi
from
Yountville, CA
Clinical Characteristics of Dementias That Occur Remotely After Traumatic Brain Injury in Retired Military Personnel
Endophenotypes of Dementia Associated With Traumatic Brain Injury in Retired Military Personnel
Status: Enrolling
Updated: 12/31/1969
California Veterans Home-Yountville
mi
from
Yountville, CA
Click here to add this to my saved trials
Clinical Characteristics of Dementias That Occur Remotely After Traumatic Brain Injury in Retired Military Personnel
Endophenotypes of Dementia Associated With Traumatic Brain Injury in Retired Military Personnel
Status: Enrolling
Updated:  12/31/1969
Armed Forces Retirement Home
mi
from
Washington,
Clinical Characteristics of Dementias That Occur Remotely After Traumatic Brain Injury in Retired Military Personnel
Endophenotypes of Dementia Associated With Traumatic Brain Injury in Retired Military Personnel
Status: Enrolling
Updated: 12/31/1969
Armed Forces Retirement Home
mi
from
Washington,
Click here to add this to my saved trials
Reducing Agitation in People With Dementia: the Customized Activity Trial
Reducing Agitation in People With Dementia: the Customized Activity Trial
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University School of Nursing, Center for Innovative Care in Aging
mi
from
Baltimore, MD
Reducing Agitation in People With Dementia: the Customized Activity Trial
Reducing Agitation in People With Dementia: the Customized Activity Trial
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University School of Nursing, Center for Innovative Care in Aging
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
Status: Enrolling
Updated:  12/31/1969
Novartis Investigator Site
mi
from
Birmingham, AL
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
Status: Enrolling
Updated: 12/31/1969
Novartis Investigator Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative site
mi
from
Los Angeles, CA
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
San Francisco, CA
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Miami, FL
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Miami, FL
Click here to add this to my saved trials
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Orlando, FL
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Orlando, FL
Click here to add this to my saved trials
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Tallahassee, FL
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative site
mi
from
Boston, MA
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative site
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative site
mi
from
Boston, MA
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative site
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Detroit, MI
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Detroit, MI
Click here to add this to my saved trials
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
New Brunswick, NJ
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Philadelphia, PA
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Salt Lake City, UT
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Parkville,
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Parkville,
Click here to add this to my saved trials
Children With Hemiparesis Arm and Hand Movement Project (CHAMP Study)
A Multisite Trial of Pediatric Constraint-Induced Movement Therapy
Status: Enrolling
Updated:  12/31/1969
Virginia Tech Carilion Research Institute
mi
from
Roanoke, VA
Children With Hemiparesis Arm and Hand Movement Project (CHAMP Study)
A Multisite Trial of Pediatric Constraint-Induced Movement Therapy
Status: Enrolling
Updated: 12/31/1969
Virginia Tech Carilion Research Institute
mi
from
Roanoke, VA
Click here to add this to my saved trials
Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia
A Phase 1, Randomized, Double-blind, Placebo-controlled, Multicenter, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral VP 20629 in Adult Subjects With Friedreich's Ataxia
Status: Enrolling
Updated:  12/31/1969
UCLA Medical Center
mi
from
Los Angeles, CA
Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia
A Phase 1, Randomized, Double-blind, Placebo-controlled, Multicenter, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral VP 20629 in Adult Subjects With Friedreich's Ataxia
Status: Enrolling
Updated: 12/31/1969
UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia
A Phase 1, Randomized, Double-blind, Placebo-controlled, Multicenter, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral VP 20629 in Adult Subjects With Friedreich's Ataxia
Status: Enrolling
Updated:  12/31/1969
University of South Florida
mi
from
Tampa, FL
Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia
A Phase 1, Randomized, Double-blind, Placebo-controlled, Multicenter, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral VP 20629 in Adult Subjects With Friedreich's Ataxia
Status: Enrolling
Updated: 12/31/1969
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia
A Phase 1, Randomized, Double-blind, Placebo-controlled, Multicenter, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral VP 20629 in Adult Subjects With Friedreich's Ataxia
Status: Enrolling
Updated:  12/31/1969
University of Iowa Children's Hospital
mi
from
Iowa City, IA
Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia
A Phase 1, Randomized, Double-blind, Placebo-controlled, Multicenter, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral VP 20629 in Adult Subjects With Friedreich's Ataxia
Status: Enrolling
Updated: 12/31/1969
University of Iowa Children's Hospital
mi
from
Iowa City, IA
Click here to add this to my saved trials
Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia
A Phase 1, Randomized, Double-blind, Placebo-controlled, Multicenter, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral VP 20629 in Adult Subjects With Friedreich's Ataxia
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia
A Phase 1, Randomized, Double-blind, Placebo-controlled, Multicenter, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral VP 20629 in Adult Subjects With Friedreich's Ataxia
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia
A Phase 1, Randomized, Double-blind, Placebo-controlled, Multicenter, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral VP 20629 in Adult Subjects With Friedreich's Ataxia
Status: Enrolling
Updated:  12/31/1969
Emory University
mi
from
Atlanta, GA
Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia
A Phase 1, Randomized, Double-blind, Placebo-controlled, Multicenter, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral VP 20629 in Adult Subjects With Friedreich's Ataxia
Status: Enrolling
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Upper Extremity Surgery in Spinal Cord Injury
Study of the Surgical Treatment of Cervical Spinal Cord Injuries With Nerve Transfers to Restore Upper Extremity and Hand Function
Status: Enrolling
Updated:  12/31/1969
Washington University Division of Plastic Surgery
mi
from
Saint Louis, MO
Upper Extremity Surgery in Spinal Cord Injury
Study of the Surgical Treatment of Cervical Spinal Cord Injuries With Nerve Transfers to Restore Upper Extremity and Hand Function
Status: Enrolling
Updated: 12/31/1969
Washington University Division of Plastic Surgery
mi
from
Saint Louis, MO
Click here to add this to my saved trials
DHA For The Treatment of Pediatric Concussion Related to Sports Injury
Docosahexaenoic Acid (DHA) For The Treatment of Pediatric Concussion Related to Sports Injury
Status: Enrolling
Updated:  12/31/1969
Sports Medicine at Texas Scottish Rite Hospital for Children
mi
from
Plano, TX
DHA For The Treatment of Pediatric Concussion Related to Sports Injury
Docosahexaenoic Acid (DHA) For The Treatment of Pediatric Concussion Related to Sports Injury
Status: Enrolling
Updated: 12/31/1969
Sports Medicine at Texas Scottish Rite Hospital for Children
mi
from
Plano, TX
Click here to add this to my saved trials
Peanut Epicutaneous Phase II Immunotherapy Clinical Trial
Epicutaneous Immunotherapy (EPIT) for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled, Phase II Study in Children and Adults (DAIT COFAR6)
Status: Enrolling
Updated:  12/31/1969
Arkansas Children's Hospital
mi
from
Little Rock, AR
Peanut Epicutaneous Phase II Immunotherapy Clinical Trial
Epicutaneous Immunotherapy (EPIT) for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled, Phase II Study in Children and Adults (DAIT COFAR6)
Status: Enrolling
Updated: 12/31/1969
Arkansas Children's Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
Peanut Epicutaneous Phase II Immunotherapy Clinical Trial
Epicutaneous Immunotherapy (EPIT) for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled, Phase II Study in Children and Adults (DAIT COFAR6)
Status: Enrolling
Updated:  12/31/1969
National Jewish Health
mi
from
Denver, CO
Peanut Epicutaneous Phase II Immunotherapy Clinical Trial
Epicutaneous Immunotherapy (EPIT) for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled, Phase II Study in Children and Adults (DAIT COFAR6)
Status: Enrolling
Updated: 12/31/1969
National Jewish Health
mi
from
Denver, CO
Click here to add this to my saved trials
Peanut Epicutaneous Phase II Immunotherapy Clinical Trial
Epicutaneous Immunotherapy (EPIT) for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled, Phase II Study in Children and Adults (DAIT COFAR6)
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Peanut Epicutaneous Phase II Immunotherapy Clinical Trial
Epicutaneous Immunotherapy (EPIT) for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled, Phase II Study in Children and Adults (DAIT COFAR6)
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Peanut Epicutaneous Phase II Immunotherapy Clinical Trial
Epicutaneous Immunotherapy (EPIT) for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled, Phase II Study in Children and Adults (DAIT COFAR6)
Status: Enrolling
Updated:  12/31/1969
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Peanut Epicutaneous Phase II Immunotherapy Clinical Trial
Epicutaneous Immunotherapy (EPIT) for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled, Phase II Study in Children and Adults (DAIT COFAR6)
Status: Enrolling
Updated: 12/31/1969
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Peanut Epicutaneous Phase II Immunotherapy Clinical Trial
Epicutaneous Immunotherapy (EPIT) for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled, Phase II Study in Children and Adults (DAIT COFAR6)
Status: Enrolling
Updated:  12/31/1969
University of North Carolina at Chapel Hill School of Medicine
mi
from
Chapel Hill, NC
Peanut Epicutaneous Phase II Immunotherapy Clinical Trial
Epicutaneous Immunotherapy (EPIT) for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled, Phase II Study in Children and Adults (DAIT COFAR6)
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill School of Medicine
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Study of Movement Disorders Using the QMAT At-Home Testing Device
A Longitudinal Study Assessing the Pathophysiology of Movement Disorders Utilizing the QMAT at Home Testing Device
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
A Study of Movement Disorders Using the QMAT At-Home Testing Device
A Longitudinal Study Assessing the Pathophysiology of Movement Disorders Utilizing the QMAT at Home Testing Device
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Cognitive Oriented Strategy Training Augmented Rehabilitation (COSTAR) Treatment Approach for Stroke
Cognitive Oriented Strategy Training Augmented Rehabilitation (COSTAR) Treatment Approach for Stroke
Status: Enrolling
Updated:  12/31/1969
Washington University in St Louis: Program in Occupational Therapy
mi
from
Saint Louis, MO
Cognitive Oriented Strategy Training Augmented Rehabilitation (COSTAR) Treatment Approach for Stroke
Cognitive Oriented Strategy Training Augmented Rehabilitation (COSTAR) Treatment Approach for Stroke
Status: Enrolling
Updated: 12/31/1969
Washington University in St Louis: Program in Occupational Therapy
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Wahls Paleo Diet and Progressive Multiple Sclerosis
Wahls Paleo Diet and Progressive Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Univeristy of Iowa
mi
from
Iowa City, IA
Wahls Paleo Diet and Progressive Multiple Sclerosis
Wahls Paleo Diet and Progressive Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Univeristy of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Characterization of Familial Myopathy and Paget Disease of Bone
Phase 1 Study Non-invasive Use Diffuse Optical Spectroscopy Will Measure the Concentrations of Blood, Water, and Lipids (Fats, for Example) in Tissues
Status: Enrolling
Updated:  12/31/1969
Beckman Laser Institute Medical clinic
mi
from
Irvine, CA
Characterization of Familial Myopathy and Paget Disease of Bone
Phase 1 Study Non-invasive Use Diffuse Optical Spectroscopy Will Measure the Concentrations of Blood, Water, and Lipids (Fats, for Example) in Tissues
Status: Enrolling
Updated: 12/31/1969
Beckman Laser Institute Medical clinic
mi
from
Irvine, CA
Click here to add this to my saved trials
Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis
A Single Arm, Open-label, Multicenter Study Evaluating the Long-term Safety and Tolerability of 0.5 mg Fingolimod (FTY720) Administered Orally Once Daily in Patients With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Cullman, AL
Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis
A Single Arm, Open-label, Multicenter Study Evaluating the Long-term Safety and Tolerability of 0.5 mg Fingolimod (FTY720) Administered Orally Once Daily in Patients With Relapsing Forms of Multiple Sclerosis
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Cullman, AL
Click here to add this to my saved trials